Conmed Corporation (CNMD) - Bear of the Day

By Zacks.com,  October 09, 2012, 01:00:01 AM EDT

We downgrade our recommendation on Conmed Corporation ( CNMD ) to Underperform. Its earnings and revenues for the second quarter missed the Zacks Consensus Estimates. All business segments, except the Arthroscopy business, hampered growth and sales. Conmed has lowered its guidance for 2012.

The company competes in the orthopedic surgery market against much larger, more technically-competent companies with deeper pockets. It continues to face a weak capital purchasing environment. We are also keeping an eye on Conmed's multiple given the current headwinds.

Thus, we downgrade our recommendation on Conmed to Underperform with a price target of $27 based on 15.3x our fiscal 2012 earnings estimate. Over the last five years, the company's shares have traded in a range of 8.9x to 22.6x, trailing 12-month earnings.
 
CONMED CORP (CNMD): Free Stock Analysis Report
 
To read this article on Zacks.com click here.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: Investing, Investing Ideas, Stocks

Referenced Stocks: CNMD



Latest News Video

Mad Money Uncovered: CREE Is In
Mad Money Uncovered: CREE Is In     
Raw Video of Oklahoma Tornadoes
Raw Video of Oklahoma Tornadoes     
Why Did UK Inflation Rate Fall?
Why Did UK Inflation Rate Fall?     


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into to the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.

From Our Trusted News Source





Most Active by Volume:

Company Last Sale Change Net / %
BAC $ 13.51 0.08  0.60%
RAD $ 2.80 0.01  0.36%
CSCO $ 23.94 0.30  1.24%
MSFT $ 35.06 0.19  0.54%
WCRX $ 19.60 0.39  2.03%
SIRI $ 3.49 0.01  0.29%
FB $ 25.76 0.49  1.87%
S $ 7.29 0.03  0.41%